M eningioMas are one of the more common intracranial neoplasms, accounting for 20% of all brain tumors and with a national annual incidence of 6 cases per 100,000 persons. 32, 40 Patients may present with or develop new-onset seizures and epilepsy secondary to their lesion, potentially leading to aspiration, brain edema, and secondary brain injury. This risk often leads practitioners to administer prophylactic AEDs at the time of surgery, regardless of whether the patient has experienced a seizure. This practice remains controversial, however, with previous studies reaching conflicting results. Moreover, recent studies have focused on AED side effects, indicating that these medications may limit functional recovery and suggesting that such treatment should be limited to patients with a seizure disorder.
M eningioMas are one of the more common intracranial neoplasms, accounting for 20% of all brain tumors and with a national annual incidence of 6 cases per 100,000 persons. 32, 40 Patients may present with or develop new-onset seizures and epilepsy secondary to their lesion, potentially leading to aspiration, brain edema, and secondary brain injury. This risk often leads practitioners to administer prophylactic AEDs at the time of surgery, regardless of whether the patient has experienced a seizure. This practice remains controversial, however, with previous studies reaching conflicting results. Moreover, recent studies have focused on AED side effects, indicating that these medications may limit functional recovery and suggesting that such treatment should be limited to patients with a seizure disorder.
To gain a more complete understanding regarding the efficacy of prophylactic AED therapy in this patient population, it is important to quantify and compare the rates of seizures and medication-related side effects between those patients who receive prophylactic AEDs and those that do not. To this end, we performed a systematic meta-analysis of outcomes following supratentorial meningioma resection with and without prophylactic AED administration in the hope of clarifying the role of AEDs in the perioperative care of patients with these lesions.
Methods

Study Selection
We performed a literature search using the PubMed gateway of the MEDLINE database and searching studies published between the years of 1979 and 2010. The folProphylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy A review lowing key words were queried singly and/or in combination: meningioma, supratentorial, epilep*, seiz*, convul*, antiepilep*, anticonvul*, antiseiz*, prophyla*, phenytoin, valpro*, levetiracetam, where * is a truncation character that retrieves all word endings. The search was limited to studies published in English, with "Humans" specified as the study category.
Eligibility criteria were limited by the nature of existing literature on this topic, which consists largely of retrospective case series and case reports. All publications recording AED use and seizure outcomes following surgery for supratentorial meningioma patients with no prior history of seizures were selected, whereas editorials, commentaries, and review articles were excluded. For mixed series including patients with other tumor types or patients presenting with seizures, applicable patients were only included where individual outcomes could be ascertained from the original article. A manual search for manuscripts was also conducted by scrutinizing references from identified manuscripts, major neurosurgical journals and texts, and personal files. The date of last search was September 2010.
Data Extraction
Included studies were reviewed and carefully scrutinized for study design, methodology, patient characteristics, and primary findings by 2 independent researchers (D.M.S.R., J.B.I.). The total number of patients for each study was extracted and divided into cohorts according to perioperative AED use. Data for all patients were recorded when available, including mean age, sex, tumor location, preoperative signs and symptoms, previous surgery, preexisting seizure disorder or AED use, and operative approaches. Antiepileptic drug use, extent of resection, adjuvant treatments, mortality, and recurrences were noted. Postoperative seizures were classified as "early" if they occurred prior to hospital discharge, and as "late" if they occurred after discharge.
Statistical Analysis
Data from the individual studies were combined by cohort and subsequently compared. Statistical analyses of categorical variables were carried out using chi-square and Fisher exact tests, as appropriate. Odds ratios and 95% CIs were calculated using logistic regression analysis. Individual analysis of heterogeneity was not carried out due to a significant difference between cohorts and reported outcomes. Differences were acknowledged to be statistically significant at p < 0.05.
Results
Study Selection
A total of 12,029 studies published since 1979 were identified through our initial MEDLINE database search. After removal of duplicates, all records were screened by review of abstracts for suitability. The full text of all records with reference to "meningioma" or "tumor" was downloaded and filtered by mention of AED prophylaxis using a combination of search terms (epilep*, seiz*, convul*, and so forth) Applicable records were thoroughly reviewed for final inclusion or exclusion. Altogether, 12,010 records were rejected from our review because they did not include original data, did not report seizure outcomes, were not restricted to supratentorial meningiomas presenting with no prior seizure history, or did not differentiate those who received AED prophylaxis from those who did not. Any study that included patients who presented with seizures was excluded from this analysis, unless individual data for patients who did not present with seizures could be extracted from the study, because the purpose of this study was to evaluate a strategy of AED prophylaxis in otherwise seizure-naïve subjects. Thirteen studies reported seizure outcomes among cohorts of patients with supratentorial meningiomas who received AED prophylaxis, and 3 studies reported outcomes in those who did not receive AED prophylaxis. An additional 3 studies compared cohorts of patients who received AEDs with those who did not receive AEDs. A total of 19 studies and 698 patients were included in this review.
Study Characteristics
Characteristics and primary findings of the 16 included studies of meningioma resection in patients receiving AEDs are summarized in Table 1 and 2 randomized controlled trials. 5, 26 Characteristics of the 6 studies investigating meningioma resection in patients not receiving AEDs are summarized in Table 2 . Regarding study design, 3 papers were retrospective, 14, 33, 39 1 was prospective, 20 and there was 1 case report 42 and 1 randomized controlled trial. 26 
Patient Characteristics
Patient characteristics of cohorts in which AED prophylaxis was used and those in which there was no AED prophylaxis are reported in Table 3 . In the AED cohort there were 553 patients, with an age range of 21-84 years (mean age 55.9 years) and a follow-up range of 1-112 months (mean 36.5 months); 27.5% of the patients in this cohort were male. Presenting symptoms included visual disturbance in 105 (80.2%) of 131 reported cases, headache in 55 (41.4%) of 133 cases, and mental disturbance in 32 (29.6%) of 108. Previous surgery was reported in 18 (10.8%) of 167 cases. The mean maximum diameter of lesions encountered was 4.23 cm. In the no-AED cohort there were 145 patients, with an age range of 12-75 years (mean 52.9 years) and follow-up range of 1-84 months (mean 38.6 months); 19.0% of the patients in this cohort were male. Presenting symptoms included visual disturbance in 44 (72.1%) of 61 reported cases, headache in 12 (20.0%) of 60 cases, and mental disturbance in 2 (20.0%) of 10 cases. Previous surgery was reported in 4 (7.8%) of 51 cases. The mean maximum diameter of lesions encountered was not reported in any studies. The 2 cohorts did not differ significantly in any patient or tumor characteristics.
Antiepileptic Drug Characteristics
Prophylactic AED therapy was used in all 553 cases in the AED cohort. The most commonly used anticonvulsants were phenytoin (Dilantin, diphenylhydantoin), valproic acid (Depakote), carbamazepine, lamotrigine (Lamictal), and levetiracetam (Keppra). Adverse events due to AED use were reported in only 1 case report, and discontinuation or switching of AED was required in that same case report.
Outcomes and Complications
Outcomes and complications in the AED and no-AED cohorts are reported in Table 4 .
Extent of Resection.
In the AED cohort, gross-total resection was reported in 6 studies and occurred in 69.2% of patients (119 of 172). The incidence of subtotal resection was 10.3%, and partial resection (as defined by the individual studies' authors) was achieved in 17.9%. In the no-AED cohort, gross-total resection was reported in 3 studies and occurred in 85.2% of patients (52 of 61); subtotal resection was achieved in 13.7%, and partial resection in no cases. There was a significantly larger proportion of gross-total resections in the no-AED cohort than in the AED cohort (85.2% vs 69.2% respectively, p < 0.05), whereas the AED cohort exhibited significantly higher rates of partial resections than the no-AED cohort (17.9% vs 0% respectively, p < 0.01).
Postoperative Seizures and Clinical
Outcome. In the AED cohort, early seizure occurred in 1.4% of cases (8 of 553), and late seizure occurred in 8.8% of cases (42 of 475). The mean time to seizure was 42 months in 1 study in which this was reported. The perioperative mortality rate was 0.2% (1 death in 553 cases). Recurrence occurred in 27 (17.3%) of 156 cases at a mean time of 67.9 months (range 28-92 months). In the no-AED cohort, early seizure occurred in 1.4% of cases (2 of 145), and late seizure occurred in 9.0% of cases (13 of 145). The mean time to seizure was 2.3 days (range 0-3 days) in the studies in which this was reported. The perioperative mortality rate 0.7% (1 death in 145 reported cases). Recurrence oc- There was no significant difference in the rate of early (1.4% vs 1.4%, p > 0.05) or late (8.8% vs 9.0%, p > 0.05) postoperative seizures between the AED and no-AED groups. Likewise, there was no significant difference in perioperative mortality (0.2% vs 0.7%, p > 0.05) or recurrence (17.3% vs 20.0%, p > 0.05) between the AED and no-AED cohorts (Fig. 1) .
Discussion
Seizures are a well-described consequence of supratentorial meningiomas, both in the natural history of the disease 10, 11, 16 and following tumor resection. Although AEDs have shown some efficacy in preventing epilepsy in patients undergoing craniotomy in early series, 26, 27 modern series have demonstrated low rates of postoperative seizures even in those not receiving AED prophylaxis, bringing this practice into question. 14, 33, 39, 42 Moreover, AEDs are known to be associated with side effects, providing further impetus for formalized evidence-based guidelines regarding prophylactic AED administration. 23 In 2000, the American Academy of Neurology produced practice guidelines recommending against the use of AEDs in patients with newly diagnosed brain tumors, 15 citing a lack of efficacy in their meta-analysis of four Level 1 studies and an increased incidence of adverse events in this patient population. Nevertheless, no clear consensus has been reached in the neurosurgical community regarding the perioperative use of prophylactic AEDs for supratentorial meningioma removal in either the urgent or elective setting. Thus, these drugs continue to be used on a routine basis in many practices.
To fully understand the efficacy of prophylactic AEDs in patients undergoing supratentorial meningioma resection, we reviewed the modern literature and compared the postoperative seizure rates in patients without seizure history who received perioperative AEDs versus those that did not. The primary conclusion is as follows: the routine use of prophylactic AEDs in patients undergoing resection of supratentorial meningiomas provides no benefit in the reduction of either early (in-hospital; AED 1.4% vs no AED 1.4%, p > 0.05) or late (postdischarge; AED 8.8% vs. no AED 9.0%, p > 0.05) seizures. Unfortunately, the incidence of complications related to perioperative anticonvulsant administration was poorly reported, remains ill-defined, and deserves further investigation.
New-onset seizures following resection of supratentorial meningiomas have been reported throughout the literature. In a recent cohort, Sughrue et al. 39 compared patients treated with either 1 week of prophylactic AED therapy or with no AED therapy after convexity meningioma resection. There was one postoperative seizure in the no-AED group (1.6%), but no significant difference in postoperative seizures between the groups. Morokoff et al. 25 reported a 1.2% incidence of late seizures in their AED-treated cohort of patients undergoing resection of convexity meningiomas. Among patients undergoing craniotomy for meningioma removal without AED prophylaxis, Lieu and Howng 21 reported a de novo seizure incidence of 18.4%, and Puchner and colleagues 33 reported a 12% postoperative seizure rate. More specifically, phenytoin has been investigated in a number of studies, with postoperative seizure rates ranging between 0% and 20%. 6, 18, 26, 28 In a seminal study published in 1983, North et al. 26 compared perioperative phenytoin prophylaxis with placebo administration in the prevention of seizures following craniotomy. These authors demonstrated a 50% reduction in seizure frequency; however, among the meningioma patients in this study there was an equivalent rate of seizure in the phenytoin and placebo groups (2/10 vs 2/9 patients, respectively). Lee and colleagues 20 compared a slightly different regimen of antiepileptic prophylaxis in their cohort; although there were more seizures in those not receiving AED prophylaxis, the difference was not statistically significant. Chozick et al. 8 demonstrated that preoperative seizure history, rather than AED prophylaxis with phenytoin, was the main predictor of postoperative seizures in their cohort.
Moving forward, it is important to clearly understand the pathophysiology of seizures and the pharmacology of AEDs. There are 3 mechanisms by which a seizure may occur in the setting of neurosurgery for supratentorial meningiomas. These are: 1) intrinsic epileptogenic nature of the tumor, particularly in certain locations such as temporal and parietal lobes; 4,37 2) surgical factors associated with craniotomy (brain retraction and cortical irritation); and 3) postsurgical complications such as hydrocephalus, edema, or infection. The relative contribution of each of these factors to incident seizures that occur after meningioma resection remains unclear. Intrinsic tumor-related seizures may arise through a different pathogenic mechanism than those occurring as part of an idiopathic epileptic syndrome. Although incompletely understood, tumorassociated seizures are thought to arise either through alteration of brain homeostasis via mass effect, alteration of intracranial acid/base status via peritumoral edema or secretions, or disturbance in neurotransmitter pathways. 4, 36 Tumor-related epilepsy and tumor growth have been hypothesized to share common molecular pathways, 4 which may explain how tumor removal can cure tumor-related epilepsy in some cases. Most AEDs work by dampening neuronal excitability by inhibiting excitatory neurotransmitter release, which-though effective in idiopathic epilepsy-may have little pathophysiological justification in patients with brain tumors.
Traditional AEDs such as phenytoin, carbamazepine, and valproic acid are metabolized via the hepatic cytochrome P450 system 24 and interact with a number of drugs that may be concomitantly used in patients with meningiomas, including chemotherapeutic agents and steroids. 31, 46, 47 Phenytoin increases the metabolism of the steroid dexamethasone, and when given together, the activity of both drugs may be decreased in an unpredictable fashion. 35 Weaning patients off dexamethasone after meningioma surgery represents a particular danger, and not coincidentally, this occurs during the peak period for postoperative seizures. The interactions between chemotherapeutic drugs and anticonvulsants are also well-described and may complicate postoperative treatment. 32, 46, 47 Most of the newer AEDs, such as levetiracetam 38 and gabapentin, 9 are excreted without appreciable metabolism through cytochrome P450 -independent mechanisms and may avoid some of these adverse interactions. However, cohorts that used these AEDs in our analysis showed no lower incidence of postoperative seizure than any other anticonvulsant.
Surgical factors may also contribute to postoperative seizures in patients with supratentorial meningiomas. Phenytoin may have a neuroprotective effect against acute ischemic injury, which may be beneficial in the prevention of seizure in this situation. 34, 41 However, AEDs have not been shown to prevent epileptogenesis in a previously asymptomatic brain. 7 The observation from early work that the rate of seizure increased following cessation of AED therapy postcraniotomy 26 prompted the suggestion that, instead of providing true seizure prevention, phenytoin may merely mask seizure activity from manifesting clinically. 3 Furthermore, AED use may be associated with significant morbidity. Intolerable side effects have been reported in up to 18% of patients taking AEDs. 22 Among the papers included in this analysis, only 2 reported adverse events, and 4 reported incidence of switching or discontinuation of AEDs due to adverse effects of the medication. Medication-related adverse effects are almost certainly underreported in the cohorts included in this review, partly because the aim of most of these studies was not to specifically investigate AEDs, but to report outcomes following supratentorial meningioma resection. Thus, medication-related events were not captured in great detail in the original analysis. Determining the true incidence of AED-related adverse effects would be useful in evaluating the risk-benefit ratio for the rational use of AED prophylaxis.
Study Limitations
The interpretation of our results is limited, in part, by significant differences in patient demographics and clinical characteristics between the prophylactic AED and no-AED cohorts.
Importantly, in the no-AED group mean tumor diameter was not recorded. In addition, specific tumor location was not compared between the groups because most of the studies aggregated data from patients with varied supratentorial locations, and the precise location could not be ascertained. Patients with tumors in certain locations may be more susceptible to postoperative seizures and significant differences in the distribution of tumors between groups may have contributed to the difference in outcomes. There was also a significant difference in the extent of resection between cohorts, with the no-AED cohort having a greater percentage of gross-total resection. In point of fact, patients with larger or residual tumors may be more at risk for seizures and therefore more likely to benefit from prophylactic AED administration. Ultimately, it will be important to compare cases with similar size and extent of resection in each cohort. There was a large disparity in cohort size between the groups, with the majority of published cases involving patients who were administered AEDs (553 patients in the AED cohort, 145 in the no-AED cohort). This may represent a reporting bias in which studies without AED usage make no mention of whether AEDs were administered, excluding them from a systematic analysis of prophylactic AED use. There also exists the possibility that this disparity reflects a conservative approach to prophylaxis that, although widespread, is not evidence based. In neither of the cohorts were patients randomized to AED prophylaxis or no AED prophylaxis groups, and most studies involved multiple surgeons of differing approaches to AED prophylaxis and technical skill, leading to selection bias and additional confounders. In addition, drug levels were not recorded, leading to the possibility that some of the patients who experienced seizures may not have been on therapeutic regimens. Lastly, study heterogeneity was considerable, as investigations from multiple centers presented varying study designs, methodologies, management paradigms, adjuvant therapies, and patient populations. Cost-effectiveness studies may provide additional evidence of the high cost and minimal benefit of these drugs when used in a prophylactic capacity for meningioma patients.
Conclusions
Our systematic analysis supports the conclusion that the routine use of AEDs in patients undergoing resection of supratentorial meningiomas has not been shown in the available literature to reduce either early (in-hospital) or late (postdischarge) seizures. Furthermore, the complications of perioperative anticonvulsant use, though they remain ill-defined in this surgical population, are likely to be nontrivial and deserve further investigation. Interpretation of these results is limited by cohort differences and a wide variation in practice of AED use between studies. Although the overall literature does not support routine AED use in this population, further prospective investigations are needed.
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